82 related articles for article (PubMed ID: 16193809)
1. The separation of EPO from other proteins in medical products formulated with different stabilizers.
Wilczyńska JD; Roman I; Anuszewska E
Acta Pol Pharm; 2005; 62(3):177-82. PubMed ID: 16193809
[TBL] [Abstract][Full Text] [Related]
2. Development of a sensitive size exclusion HPLC method with fluorescence detection for the quantitation of recombinant human erythropoietin (r-HuEPO) aggregates.
Gunturi SR; Ghobrial I; Sharma B
J Pharm Biomed Anal; 2007 Jan; 43(1):213-21. PubMed ID: 16875794
[TBL] [Abstract][Full Text] [Related]
3. Immunochromatographic removal of albumin in erythropoietin biopharmaceutical formulations for its analysis by capillary electrophoresis.
Lara-Quintanar P; Lacunza I; Sanz J; Diez-Masa JC; de Frutos M
J Chromatogr A; 2007 Jun; 1153(1-2):227-34. PubMed ID: 16919660
[TBL] [Abstract][Full Text] [Related]
4. Rapid and high-resolution glycoform profiling of recombinant human erythropoietin by capillary isoelectric focusing with whole column imaging detection.
Dou P; Liu Z; He J; Xu JJ; Chen HY
J Chromatogr A; 2008 May; 1190(1-2):372-6. PubMed ID: 18374347
[TBL] [Abstract][Full Text] [Related]
5. Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC.
Jing Q; Shen Y; Tang Y; Ren F; Yu X; Hou Z
J Pharm Biomed Anal; 2006 Jun; 41(3):1065-9. PubMed ID: 16545536
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study.
Nageswara Rao R; Narasa Raju A; Narsimha R
J Pharm Biomed Anal; 2008 Feb; 46(3):505-19. PubMed ID: 18162355
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a stability-indicating RP-HPLC method for the determination of paracetamol with dantrolene or/and cetirizine and pseudoephedrine in two pharmaceutical dosage forms.
Hadad GM; Emara S; Mahmoud WM
Talanta; 2009 Oct; 79(5):1360-7. PubMed ID: 19635371
[TBL] [Abstract][Full Text] [Related]
8. Determination and quantification of cetirizine HCl in dosage formulations by RP-HPLC.
Arayne MS; Sultana N; Siddiqui FA
Pak J Pharm Sci; 2005 Jul; 18(3):7-11. PubMed ID: 16380337
[TBL] [Abstract][Full Text] [Related]
9. Investigation of chromatographic conditions for the separation of ofloxacin and its degradation products.
Zivanovic Lj; Zigic G; Zecevic M
J Chromatogr A; 2006 Jun; 1119(1-2):224-30. PubMed ID: 16551467
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the utility of ion mobility separation in combination with high-pressure liquid chromatography/mass spectrometry to facilitate detection of trace impurities in formulated drug products.
Eckers C; Laures AM; Giles K; Major H; Pringle S
Rapid Commun Mass Spectrom; 2007; 21(7):1255-63. PubMed ID: 17340559
[TBL] [Abstract][Full Text] [Related]
11. HPLC separation technique for analysis of bufuralol enantiomers in plasma and pharmaceutical formulations using a vancomycin chiral stationary phase and UV detection.
Hefnawy MM; Sultan MA; Al-Shehri MM
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):328-36. PubMed ID: 17681871
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a capillary zone electrophoresis method for assessment of recombinant human granulocyte colony-stimulating factor in pharmaceutical formulations and its correlation with liquid chromatography methods and bioassay.
Dalmora SL; D'Avila FB; da Silva LM; Bergamo AC; Zimmermann ES
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2471-6. PubMed ID: 19560410
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of buclizine hydrochloride in pharmaceutical formulations and human serum by RP-HPLC.
Arayne MS; Sultana N; Siddiqui FA
Pak J Pharm Sci; 2006 Oct; 19(4):326-9. PubMed ID: 17105713
[TBL] [Abstract][Full Text] [Related]
14. A new universal high-performance liquid chromatographic method for determination of 1,4-benzodiazepines as bulk drugs and in pharmaceutical formulations.
Kazemifard AG; Javadzadeh N; Gholami K
Acta Pol Pharm; 2008; 65(2):179-86. PubMed ID: 18666423
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of stationary phases for 2-dimensional HPLC of proteins Part 1. Validation of commercial RP-columns.
Reh E; Hahn B; Lamotte S
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Dec; 844(2):204-12. PubMed ID: 16935574
[TBL] [Abstract][Full Text] [Related]
16. Analysis of recombinant human erythropoietin in drug formulations by high-performance capillary electrophoresis.
Bietlot HP; Girard M
J Chromatogr A; 1997 Jan; 759(1-2):177-84. PubMed ID: 9050223
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats.
Zhu B; Wang W; Gu Q; Xu X
Exp Eye Res; 2008 Feb; 86(2):375-82. PubMed ID: 18191124
[TBL] [Abstract][Full Text] [Related]
18. Analytical aspects of the stabilization of drugs in pharmaceutical formulations.
Raether G
Acta Pharm Hung; 1991 Sep; 61(5):231-8. PubMed ID: 1785352
[TBL] [Abstract][Full Text] [Related]
19. Stability evaluation of amoxicillin in a solid premix veterinary formulation by monitoring the degradation products through a new HPLC analytical method.
Pérez-Lozano P; García-Montoya E; Orriols A; Miñarro M; Ticó JR; Suñé-Negre JM
J Pharm Biomed Anal; 2006 Sep; 42(2):192-9. PubMed ID: 16765013
[TBL] [Abstract][Full Text] [Related]
20. A rapid HPLC method for simultaneous determination of tretinoin and isotretinoin in dermatological formulations.
Tashtoush BM; Jacobson EL; Jacobson MK
J Pharm Biomed Anal; 2007 Feb; 43(3):859-64. PubMed ID: 17045442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
